Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31129 ↗At a glance
Beobachtungsstudie in Catheterization and Cardiovascular Interventions, 2024. Written by Ariel Nakache and 5 co-authors. Institution: Cardiology Department, Centre Cardiologique du Nord, Saint Denis, France. Major MEDLINE topics: Radial Artery, Hemostatic Techniques, Punctures, Catheterization, Peripheral. Cited 3 times so far (Crossref); 27 references.
Abstract (original language)
Background
Radial access is the default approach in interventional cardiology. The Axiostat® surgical hemostatic dressing, using chitosan as its active component, has demonstrated potential in accelerating blood clotting. This study aims to assess the efficacy and the safety of the Axiostat® dressing in achieving hemostasis in patients undergoing transradial coronary angioplasty (TRCA).
Methods
This prospective, single‐center observational study, conducted in 2022, enrolled consecutive patients undergoing TRCA, with a target of 150 participants. The primary outcome was the success rate of radial artery hemostasis at 120 min, without bleeding necessitating immediate re‐compression. The secondary outcome included Axiostat® performance at 24 h and 30 days Postprocedure.
Results
The study was terminated prematurely for ethical and patient safety reasons, after inclusion of 41 consecutive TRCA patients due to an unexpectedly high radial artery thrombosis rate (19.5%, n = 8/41) observed 24 h Postprocedure. The success rate of radial hemostasis with the Axiostat® dressing was 78.0%. Procedural details and patient characteristics were comparable between successful Axiostat® removal and device failure cases.
Conclusion
The use of the Axiostat® dressing to achieve hemostasis after TRCA is effective but is associated with an unexpectedly high incidence of radial thrombosis. Our results should encourage caution in the future evaluation and use of this device for radial artery compression following TRCA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Cardiology Department, Centre Cardiologique du Nord, Saint Denis, France.
ORCID profiles: Franck Digne
Cite
APA
Nakache, A., Darmon, A., Molho, A., Steinecker, M., Nejjari, M., & Digne, F. (2024). Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31129
Vancouver
Nakache A, Darmon A, Molho A, Steinecker M, Nejjari M, Digne F. Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31129
BibTeX
@article{Nakache2024,
author = {Nakache, Ariel and Darmon, Arthur and Molho, Antoine and Steinecker, Matthieu and Nejjari, Mohammed and Digne, Franck},
title = {Evaluation of the safety and efficacy of the Axiostat® dressing device to achieve radial artery access hemostasis: The R3A study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31129}
}
EUVIMED